Earnings · US stocks

Unicycive Therapeutics, Inc. (UNCY) earnings

Unicycive Therapeutics, Inc. published its quarterly report on 2026-11-16. The stock moved +0.56% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-16
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+4.23%—
3 days+0.56%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 6 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +3.63%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-11-16—-0.25+28.80%+0.56%——
2026-08-12—-0.06+81.74%+10.20%-3.80%-3.44%
2026-03-30—-0.82-80.00%+11.42%+24.41%+7.82%
2025-11-12—-0.33+38.12%+18.37%+22.34%+21.26%
2025-08-14-134.70%-0.52+25.56%-7.48%-15.19%-17.23%
2025-05-14—-0.50+19.35%-1.65%-90.20%-94.46%
2025-03-31—-2.60-271.43%+2.61%+5.39%+0.48%
2024-11-13—-0.50+67.03%-4.96%+63.22%+62.48%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: UNCY

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.